Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Cohen

Showing results (851-860 of 1,023) with videos related to

Pageof 103
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2021
Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept StudyMatthew H Taylor, Courtney B Betts, Lauren Maloney, et al.
The Journal of Biological Chemistry|July 26, 2002
Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascadeScott E Woodman, David S Park, Alex W Cohen, et al.
Lancet (London, England)|December 5, 2018
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 studyEzra E W Cohen, Denis Soulières, Christophe Le Tourneau, et al.
The Journal of Clinical Investigation|September 1, 2023
Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regressionJoseph S Dolina, Joey Lee, Spencer E Brightman, et al.
CA: a Cancer Journal for Clinicians|March 23, 2016
American Cancer Society Head and Neck Cancer Survivorship Care GuidelineEzra E W Cohen, Samuel J LaMonte, Nicole L Erb, et al.
Scandinavian Journal of Gastroenterology|June 13, 2002
Increased expression of inducible nitric oxide synthase in circulating monocytes from patients with active inflammatory bowel diseaseG Dijkstra, A J H Zandvoort, A C Muller Kobold, et al.
Annals of the Rheumatic Diseases|October 4, 2007
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task forceC Mukhtyar, O Flossmann, B Hellmich, et al.
The American Journal of Pathology|June 12, 2002
Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotypeDavid S Park, Scott E Woodman, William Schubert, et al.
Plos One|July 15, 2014
DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancerTanguy Y Seiwert, XiaoZhe Wang, Jana Heitmann, et al.
Journal of Nutrition Education and Behavior|August 12, 2025
Impact of Deimplementing Universal Free School Meals: School Food Authority PerspectivesJuliana F W Cohen, Monica D Zuercher, Dania Orta-Aleman, et al.
Pageof 103

Showing results (851-860 of 1,023) with videos related to

Sort By:
Pageof 103
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2021
Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept StudyMatthew H Taylor, Courtney B Betts, Lauren Maloney, et al.
The Journal of Biological Chemistry|July 26, 2002
Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascadeScott E Woodman, David S Park, Alex W Cohen, et al.
Lancet (London, England)|December 5, 2018
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 studyEzra E W Cohen, Denis Soulières, Christophe Le Tourneau, et al.
The Journal of Clinical Investigation|September 1, 2023
Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regressionJoseph S Dolina, Joey Lee, Spencer E Brightman, et al.
CA: a Cancer Journal for Clinicians|March 23, 2016
American Cancer Society Head and Neck Cancer Survivorship Care GuidelineEzra E W Cohen, Samuel J LaMonte, Nicole L Erb, et al.
Scandinavian Journal of Gastroenterology|June 13, 2002
Increased expression of inducible nitric oxide synthase in circulating monocytes from patients with active inflammatory bowel diseaseG Dijkstra, A J H Zandvoort, A C Muller Kobold, et al.
Annals of the Rheumatic Diseases|October 4, 2007
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task forceC Mukhtyar, O Flossmann, B Hellmich, et al.
The American Journal of Pathology|June 12, 2002
Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotypeDavid S Park, Scott E Woodman, William Schubert, et al.
Plos One|July 15, 2014
DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancerTanguy Y Seiwert, XiaoZhe Wang, Jana Heitmann, et al.
Journal of Nutrition Education and Behavior|August 12, 2025
Impact of Deimplementing Universal Free School Meals: School Food Authority PerspectivesJuliana F W Cohen, Monica D Zuercher, Dania Orta-Aleman, et al.
Pageof 103